AI-enabled virtual primary care
Counsel Health
Counsel Health pairs a free medical AI chat with one-click escalation to its own physicians, who can diagnose, prescribe, order labs, and refer, sold both directly to consumers and as a responsible AI front door to employers and health plans after a $25M Series A led by a16z and GV. The FAQ commits to HIPAA, SOC 2, no data sales, and no AI training on member data, but the now-reviewed June 23, 2024 privacy policy permits LLM-partner model improvement on user data, advertising flows that may count as sales of non-health personal information, and broad de-identified data use. Oura announced a June 2026 Oura Labs rollout in 43 U.S. states. The validation evidence is vendor-run, the savings metrics are payer-facing, and the dual consumer and enterprise identity makes whose priorities govern each deployment a live CAIHL question.
Public-source research has been drafted; final human publication review and change-log detail are still required.
Summary judgment · 55% toward patient-directed
Mixed, patient-useful access with payer-aligned economics
Individuals can choose Counsel directly and reach physicians cheaply and fast, but the company positions itself to payers and employers as a cost-saving front door that resolves issues and steers members to in-network care.
Patient agency
How this tool changes agency
Answers, prescriptions and refills, lab ordering, second opinions, referrals, appointment help, and unlimited follow-ups within a visit are concretely action-oriented.
Direct consumers opt in freely with a free tier and no insurance requirement, but it is unavailable in seven states plus DC, employer and plan members receive it as a configured benefit, Oura announced a June 2026 Oura Labs channel in 43 states, and record connection is optional consent.
Patient-facing signals
Who does this AI serve?
The consumer product gives patients cheap, fast physician access, while the enterprise pitch promises payers reduced avoidable spend, audit-ready guardrails, and steering of members to in-network resources.
Can patients tell AI is involved?
Counsel AI is clearly labeled, the FAQ explains when AI answers versus when a physician joins, and physicians enter the conversation visibly by name.
Can patients meaningfully choose?
Direct consumers opt in freely with a free tier and no insurance requirement, but it is unavailable in seven states plus DC, employer and plan members receive it as a configured benefit, Oura announced a June 2026 Oura Labs channel in 43 states, and record connection is optional consent.
Can patients correct or challenge what the AI produces?
Any conversation can be escalated to a licensed physician, and the informed consent documents a complaint policy plus state medical board routes, but no specific workflow for correcting AI answers or records is publicly described.
Does it help patients understand or act?
Answers, prescriptions and refills, lab ordering, second opinions, referrals, appointment help, and unlimited follow-ups within a visit are concretely action-oriented.
Text findings
Who is left out or burdened?
Adults-only, geography- and cost-bounded
No pediatrics and 18+ only, unavailable in Arkansas, DC, Kansas, Mississippi, Rhode Island, Washington, West Virginia, and Wisconsin, physician hours limited to 8am-9pm, $29 per visit or $199/year for unlimited access, and language and accessibility support are not disclosed.
What happens to patient data?
FAQ commitments in tension with older privacy policy
The FAQ states HIPAA and SOC 2 compliance, no data sales, no AI-model training on member data, and consent-gated record connection. The full privacy policy, last modified June 23, 2024, confirms HIPAA covered-entity handling of protected health information, but also says Counsel and its LLM partners may use user data to generate responses, improve AI models and responses, and personalize AI technology. It permits targeted-advertising flows that may be considered a sale of non-health personal information, with opt-out by email, and allows de-identified data to be used and disclosed for any purpose. Which commitment governs current practice needs vendor clarification.
Are the clinical boundaries clear?
Mostly clear, with marketing tension
The informed consent says the AI does not provide medical or clinical advice and is not a licensed provider, physicians handle treatment and prescriptions, controlled substances are excluded, emergencies go to 911, and members are told to keep an in-person PCP, yet marketing calls Counsel 'the doctor that's with you for life'.
Who defined what good looks like?
Vendor-defined
Evidence is vendor-run, including an internal HealthBench-based triage evaluation on 103 scenarios and press-release metrics of 96% issue resolution and $381 annual savings per engaged member; no independent or peer-reviewed evaluation of patient outcomes was found.
Review method
Public-source review of official homepage and FAQ, privacy policy, informed-consent document, vendor HealthBench research blog, funding press coverage, and Oura partnership announcement. No hands-on testing or independent validation.
Draft profile · Medium draft, official sources and press, privacy policy reviewed